Cargando…
Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
beta-2 microglobulin levels were measured in stored serum taken at presentation from 262 patients treated with combination chemotherapy for Kiel classification high-grade lymphoma at a single centre over a 15 year period. A significant association was found between elevated levels and advanced (Ann...
Autores principales: | Johnson, P. W., Whelan, J., Longhurst, S., Stepniewska, K., Matthews, J., Amess, J., Norton, A., Rohatiner, A. Z., Lister, T. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968369/ https://www.ncbi.nlm.nih.gov/pubmed/8471438 |
Ejemplares similares
-
Computed tomography (CT) and ultrasound (US) guided core biopsy in the management of non-Hodgkin's lymphoma.
por: Whelan, J. S., et al.
Publicado: (1991) -
Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma.
por: Dhaliwal, H. S., et al.
Publicado: (1993) -
Chlorambucil and interferon for low grade non-Hodgkin's lymphoma.
por: Rohatiner, A. Z., et al.
Publicado: (1987) -
Mediastinal large-cell lymphoma with sclerosis (MLCLS).
por: Rohatiner, A. Z., et al.
Publicado: (1994) -
Prognostic value of pretreatment serum beta-2 microglobulin level in advanced classical Hodgkin lymphoma treated in the modern era
por: Wang, Qin, et al.
Publicado: (2016)